Dell Technologies Inc. - DELL

DELL Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
DELL	-1.5	-1.8	6.8	43.2	2.8	85.0	143.7	386.0	1030.7	1030.7
S&P 500	-0.3	0.6	2.9	12.0	14.6	35.6	27.8	93.5	193.6	33784.4

Compare DELL with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	DELL
name	Dell Technologies Inc.
price	136.47
changes percentage	-1.47
change	-2.04
day low	135.94
day high	141.33
year high	179.70
year low	67.51
market cap	99417907120
price avg 50	120.86
price avg 200	119.62
exchange	NYSE
volume	5353434
avg volume	10107281
open	138.75
previous close	138.51
eps	5.44
pe	25.09
earnings announcement	2024-11-26T00:00:00.000+0000
shares outstanding	728496425
timestamp	2024-11-12 21:00:02

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 55.0%

Overall Quarterly Financial Health: 59.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0001571996
revenue	88425000000	102301000000	-13.56
gross profit	20869000000	22686000000	-8.01
gross profit ratio	0.24	0.22	6.43
research and development expenses	2801000000	2779000000	0.79
operating expenses	15744000000	16915000000	-6.92
interest income	305000000	100000000	205.00
interest expense	1545000000	1281000000	20.61
ebitda	8691000000	8771000000	-0.91
ebitdaratio	0.1	0.09	13.81
operating income	5211000000	5615000000	-7.20
operating income ratio	0.06	0.06	6.60
net income	3211000000	2442000000	31.49
net income ratio	0.04	0.02	51.03
eps	4.55	3.33	36.64

Overall Score of Annual Income Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 88,425 million in 2024 from 102,301 million in 2023 representing a change of -13.56%. This indicates a sales growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 2,801 million in 2024 from 2,779 million in 2023 representing a change of 0.79%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 15,744 million in 2024 from 16,915 million in 2023 representing a change of -6.92%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  Net Income: Net income increased to 3,211 million in 2024 from 2,442 million in 2023 representing a change of 31.49%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 4.55 in 2024 from 4.55 in 2023 representing a change of 36.64%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Gross Profit: Gross Profit decreased to 20,869 million in 2024 from 22,686 million in 2023 representing a change of -8.01%. This indicates a sales profitability decline, which is a negative sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 8,691 million in 2024 from 8,771 million in 2023 representing a change of -0.91%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 5,211 million in 2024 from 5,615 million in 2023 representing a change of -7.2%. The decrease in operating income indicates worse operational performance and decreased profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2025Q2	2025Q1	Q/Q change %
0001571996
revenue	25026000000	22244000000	12.51
gross profit	5311000000	4806000000	10.51
gross profit ratio	0.21	0.22	-1.78
research and development expenses	780000000	763000000	2.23
operating expenses	4025000000	3886000000	3.58
interest income	42000000	54000000	-22.22
interest expense	387000000	359000000	7.80
ebitda	2454000000	1793000000	36.87
ebitdaratio	0.1	0.08	21.55
operating income	1342000000	993000000	35.15
operating income ratio	0.05	0.04	20.03
net income	846000000	960000000	-11.88
net income ratio	0.03	0.04	-21.73
eps	1.19	1.36	-12.50

Overall Score of Quarterly Income Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 25,026 million in 2025Q2 from 22,244 million in 2025Q1 representing a change of 12.51%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 5,311 million in 2025Q2 from 4,806 million in 2025Q1 representing a change of 10.51%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 780 million in 2025Q2 from 763 million in 2025Q1 representing a change of 2.23%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 2,454 million in 2025Q2 from 1,793 million in 2025Q1 representing a change of 36.87%. The increase in EBITDA indicates improved operational efficiency and profitability.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 4,025 million in 2025Q2 from 3,886 million in 2025Q1 representing a change of 3.58%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Operating Income: Operating income decreased to 1,342 million in 2025Q2 from 993 million in 2025Q1 representing a change of 35.15%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 846 million in 2025Q2 from 960 million in 2025Q1 representing a change of -11.88%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 1.19 in 2025Q2 from 1.19 in 2025Q1 representing a change of -12.5%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0001571996
total assets	82089000000	89611000000	-8.39
total liabilities	84398000000	92636000000	-8.89
total equity	-2309000000	-3025000000	23.67
cash and cash equivalents	7366000000	8879000000	-17.04
short term investments	40000000	0	NaN
long term investments	1316000000	7745000000	-83.01
total current assets	35947000000	39351000000	-8.65
total non current assets	46142000000	50260000000	-8.19
total current liabilities	48494000000	51654000000	-6.12
total non current liabilities	35904000000	40982000000	-12.39
common stock	8926000000	8424000000	5.96
retained earnings	-4630000000	-6732000000	31.22
total debt	25994000000	30478000000	-14.71

Overall Score of Annual Balance Sheet

0.7 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 82,089 million in 2024 from 89,611 million in 2023 representing a change of -8.39%. Suggesting a decrease in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 7,366 million in 2024 from 8,879 million in 2023 representing a change of -17.04%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 35,947 million in 2024 from 39,351 million in 2023 representing a change of -8.65%. This indicates a worsen liquidity position.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 84,398 million in 2024 from 92,636 million in 2023 representing a change of -8.89%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to -2,309 million in 2024 from -3,025 million in 2023 representing a change of 23.67%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 40 million in 2024 from 0 million in 2023 representing a change of nan%. This indicates an increase in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities decreased to 48,494 million in 2024 from 51,654 million in 2023 representing a change of -6.12%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 8,926 in 2024 from 8,424 in 2023 representing a change of 5.96%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to -4,630 million in 2024 from -6,732 million in 2023 representing a change of 31.22%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 25,994 million in 2024 from 30,478 million in 2023 representing a change of -14.71%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2025Q2	2025Q1	Q/Q change %
0001571996
total assets	82687000000	80190000000	3.11
total liabilities	85484000000	82913000000	3.10
total equity	-2797000000	-2723000000	-2.72
cash and cash equivalents	4550000000	5957000000	-23.62
short term investments	123000000	0	NaN
long term investments	1302000000	7273000000	-82.10
total current assets	37543000000	34627000000	8.42
total non current assets	45144000000	45563000000	-0.92
total current liabilities	52033000000	47734000000	9.01
total non current liabilities	33451000000	35179000000	-4.91
common stock	8782000000	8606000000	2.05
retained earnings	-3478000000	-4001000000	13.07
total debt	24522000000	26242000000	-6.55

Overall Score of Quarterly Balance Sheet

0.6 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 82,687 million in 2025Q2 from 80,190 million in 2025Q1 representing a change of 3.11%. Suggesting a growth in asset holdings.

  Short Term Investments: Short Term Investments increased to 123 million in 2025Q2 from 0 million in 2025Q1 representing a change of nan%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 37,543 million in 2025Q2 from 34,627 million in 2025Q1 representing a change of 8.42%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 8,782 in 2025Q2 from 8,606 in 2025Q1 representing a change of 2.05%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to -3,478 million in 2025Q2 from -4,001 million in 2025Q1 representing a change of 13.07%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 24,522 million in 2025Q2 from 26,242 million in 2025Q1 representing a change of -6.55%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 85,484 million in 2025Q2 from 82,913 million in 2025Q1 representing a change of 3.1%. This indicates an increase in overall liabilities.

  Total Equity: Total Equity decreased to -2,797 million in 2025Q2 from -2,723 million in 2025Q1 representing a change of -2.72%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 4,550 million in 2025Q2 from 5,957 million in 2025Q1 representing a change of -23.62%. This indicates a decrease in available liquid assets.

  Total Current Liabilities: Total Current Liabilities increased to 52,033 million in 2025Q2 from 47,734 million in 2025Q1 representing a change of 9.01%. This indicates a higher short-term debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0001571996
net change in cash	-1387000000	-1132000000	-22.53
operating cash flow	8676000000	3565000000	143.37
free cash flow	5920000000	562000000	953.38
capital expenditure	-2756000000	-3003000000	8.23
depreciation and amortization	3303000000	3156000000	4.66
deferred income tax	-91000000	-717000000	87.31
stock based compensation	878000000	0	NaN
accounts payables	-335000000	-8546000000	96.08
inventory	975000000	875000000	11.43
acquisitions net	-126000000	-70000000	-80.00
investments in property plant and equipment	-2756000000	-3003000000	8.23
net cash used for investing activites	-2783000000	-3024000000	7.97
debt repayment	-3471000000	0	NaN
common stock issued	10000000	5000000	100.00
common stock repurchased	-2452000000	-3281000000	25.27
dividends paid	-1072000000	-964000000	-11.20
net cash used provided by financing activities	-7094000000	-1625000000	-336.55
cash at end of period	7507000000	8879000000	-15.45
accounts receivables	3286000000	-348000000	1,044.25
cash at beginning of period	8894000000	10011000000	-11.16

Overall Score of Annual Cashflow Statement

0.33 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -1,387 million in 2024 from -1,132 million in 2023 representing a change of -22.53%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure increased to -2,756 million in 2024 from -3,003 million in 2023 representing a change of 8.23%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to -91 million in 2024 from -717 million in 2023 representing a change of 87.31%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 878 million in 2024 from 0 million in 2023 representing a change of nan%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to 3,286 in 2024 from -348 million in 2023 representing a change of 1044.25%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -1,072 million in 2024 from -964 million in 2023 representing a change of -11.2%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 8,676 million in 2024 from 3,565 million in 2023 representing a change of 143.37%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 5,920 million in 2024 from 562 million in 2023 representing a change of 953.38%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables decreased to 335 million in 2024 from 8,546 million in 2023 representing a change of 96.08%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2025Q2	2025Q1	Q/Q change %
0001571996
operating cash flow	1340000000	1043000000	28.48
free cash flow	658000000	447000000	47.20
capital expenditure	-682000000	-596000000	-14.43
depreciation and amortization	784000000	800000000	-2.00
deferred income tax	-17000000	-327000000	94.80
stock based compensation	191000000	0	NaN
accounts receivables	-2886000000	518000000	-657.14
accounts payables	3560000000	1241000000	186.87
inventory	-1281000000	-1236000000	-3.64
acquisitions net	0	0	NaN
investments in property plant and equipment	-682000000	-596000000	-14.43
net cash used for investing activites	-557000000	-456000000	-22.15
debt repayment	-976000000	0	NaN
common stock issued	1000000	0	NaN
common stock repurchased	-739000000	-1221000000	39.48
dividends paid	-316000000	-336000000	5.95
net cash used provided by financing activities	-2032000000	-2077000000	2.17
net change in cash	-1291000000	-1545000000	16.44
cash at end of period	4671000000	5957000000	-21.59
cash at beginning of period	5962000000	7502000000	-20.53

Overall Score of Quarterly Cashflow Statement

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -1,291 million in 2025Q2 from -1,545 million in 2025Q1 representing a change of 16.44%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 1,340 million in 2025Q2 from 1,043 million in 2025Q1 representing a change of 28.48%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 658 million in 2025Q2 from 447 million in 2025Q1 representing a change of 47.2%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -682 million in 2025Q2 from -596 million in 2025Q1 representing a change of -14.43%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Receivables: Accounts Receivables decreased to -2,886 million in 2025Q2 from 518 million in 2025Q1 representing a change of -657.14%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -316 million in 2025Q2 from -336 million in 2025Q1 representing a change of 5.95%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Deferred Income Tax: Deferred Income Tax increased to -17 million in 2025Q2 from -327 million in 2025Q1 representing a change of 94.8%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 191 million in 2025Q2 from 0 million in 2025Q1 representing a change of nan%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 3,560 million in 2025Q2 from 1,241 million in 2025Q1 representing a change of 186.87%. This indicates that the company has increased its outstanding obligations to its suppliers.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q1 2024 Earnings call transcript
Q2 2025 Earnings call transcript
Q1 2025 Earnings call transcript
Q4 2024 Earnings call transcript
Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-02-02	2023-02-03	Y/Y change %
FY
calendar year	2024	2023	NaN
revenue per share	125.19	139.37	-10.18
net income per share	4.55	3.33	36.64
operating cash flow per share	12.28	4.86	152.90
free cash flow per share	8.38	0.77	994.64
cash per share	10.49	12.1	-13.32
book value per share	-3.27	-4.12	20.68
tangible book value per share	-40.15	-30.93	-29.80
shareholders equity per share	-3.4	-4.25	19.98
interest debt per share	38.99	42.41	-8.07
market cap	60970854464.0	31004160000	96.65
enterprise value	79598854464	52603160000	51.32
pe ratio	18.99	12.7	49.56
price to sales ratio	0.69	0.3	127.51
pocfratio	7.03	8.7	-19.19
pfcf ratio	10.3	55.17	-81.33
pb ratio	-25.36	-9.93	-155.39
ptb ratio	-25.36	-9.93	-155.39
ev to sales	0.9	0.51	75.07
enterprise value over ebitda	9.16	6.0	52.71
ev to operating cash flow	9.17	14.76	-37.82
ev to free cash flow	13.45	93.6	-85.63
earnings yield	0.05	0.08	-33.14
free cash flow yield	0.1	0.02	435.65
debt to equity	-10.81	-9.56	-13.10
debt to assets	0.32	0.33	-4.93
net debt to ebitda	2.14	2.46	-12.96
current ratio	0.74	0.76	-2.70
interest coverage	3.37	4.38	-23.05
income quality	2.72	1.46	86.01
dividend yield	0.02	0.03	-43.45
payout ratio	0.33	0.39	-15.43
sales general and administrative to revenue	0.13	0	NaN
research and ddevelopement to revenue	0.03	0.03	16.61
intangibles to total assets	0.32	0.22	44.51
capex to operating cash flow	0.32	0.84	-62.29
capex to revenue	0.03	0.03	6.18
capex to depreciation	0.83	0.95	-12.31
stock based compensation to revenue	0.01	0	NaN
graham number	18.66	17.84	4.56
roic	0.18	0.16	15.08
return on tangible assets	0.06	0.03	64.09
graham net net	-91.59	-92.32	0.79
working capital	-12547000000	-12303000000	-1.98
tangible asset value	-28356000000	-22701000000	-24.91
net current asset value	-48451000000	-53285000000	9.07
invested capital	20639000000	14307000000	44.26
average receivables	16063500000	18136500000	-11.43
average payables	20027000000	24611000000	-18.63
average inventory	4199000000	5337000000	-21.32
days sales outstanding	57.73	64.73	-10.81
days payables outstanding	104.76	94.74	10.57
days of inventory on hand	19.57	21.9	-10.63
receivables turnover	6.32	5.64	12.11
payables turnover	3.48	3.85	-9.56
inventory turnover	18.65	16.67	11.89
roe	-1.34	-0.78	-70.76
capex per share	3.9	4.09	-4.63

• Negative

  ROE: Return on Equity (ROE) decreased to -1.34 on 2024-02-02 from -0.78 on 2023-02-03, representing a change of -70.76%. Suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio decreased to 0.74 on 2024-02-02 from 0.76 on 2023-02-03, representing a change of -2.70%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 18.99 on 2024-02-02 from 12.70 on 2023-02-03, representing a change of 49.56%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to -10.81 on 2024-02-02 from -9.56 on 2023-02-03, representing a change of -13.10%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-08-02 Q2	2024-05-03 Q1	Q/Q change %
DELL
calendar year	2025	2025	NaN
revenue per share	35.35	31.42	12.51
net income per share	1.19	1.36	-11.88
operating cash flow per share	1.89	1.47	28.48
free cash flow per share	0.93	0.63	47.20
cash per share	6.6	8.41	-21.55
book value per share	-3.95	-3.85	-2.72
tangible book value per share	-39.3	-31.59	-24.42
shareholders equity per share	-4.09	-3.99	-2.55
interest debt per share	35.18	36.84	-4.49
market cap	72421320000	88570800000	-18.23
enterprise value	92393320000	108855800000	-15.12
pe ratio	21.4	23.07	-7.22
price to sales ratio	2.89	3.98	-27.32
pocfratio	54.05	84.92	-36.36
pfcf ratio	110.06	198.14	-44.45
pb ratio	-25.02	-31.39	20.27
ptb ratio	-25.02	-31.39	20.27
ev to sales	3.69	4.89	-24.56
enterprise value over ebitda	37.65	60.71	-37.99
ev to operating cash flow	68.95	104.37	-33.94
ev to free cash flow	140.42	243.53	-42.34
earnings yield	0.01	0.01	7.78
free cash flow yield	0.01	0.01	80.03
debt to equity	-8.47	-9.11	7.04
debt to assets	0.3	0.32	-7.54
net debt to ebitda	8.14	11.31	-28.06
current ratio	0.72	0.73	-0.54
interest coverage	3.47	2.77	25.37
income quality	1.59	1.09	46.65
dividend yield	0.0	0.0	15.02
payout ratio	0.37	0.35	6.72
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.03	0.03	-9.14
intangibles to total assets	0.3	0.24	23.59
capex to operating cash flow	0.51	0.57	-10.93
capex to revenue	0.03	0.03	1.71
capex to depreciation	0.87	0.74	16.76
stock based compensation to revenue	0.01	0	NaN
graham number	10.48	11.03	-4.94
roic	0.05	0.08	-30.30
return on tangible assets	0.01	0.02	-7.46
graham net net	-92.61	-91.31	-1.42
working capital	-14490000000	-13107000000	-10.55
tangible asset value	-27825000000	-22363000000	-24.42
net current asset value	-47941000000	-48286000000	0.71
invested capital	17554000000	13413000000	30.87
average receivables	14791000000	13604500000	8.72
average payables	22340500000	19987500000	11.77
average inventory	5367500000	4202000000	27.74
days sales outstanding	58.83	53.5	9.96
days payables outstanding	109.99	106.25	3.53
days of inventory on hand	27.18	24.68	10.11
receivables turnover	1.53	1.68	-9.06
payables turnover	0.82	0.85	-3.41
inventory turnover	3.31	3.65	-9.18
roe	-0.29	-0.34	14.07
capex per share	0.96	0.84	14.43

• Negative

  ROE: Return on Equity (ROE) increased to -0.29 on 2024-08-02 Q2 from -0.34 on 2024-05-03 Q1, representing a change of 14.07%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 21.40 on 2024-08-02 Q2 from 23.07 on 2024-05-03 Q1, representing a change of -7.22%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio decreased to 0.72 on 2024-08-02 Q2 from 0.73 on 2024-05-03 Q1, representing a change of -0.54%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to -8.47 on 2024-08-02 Q2 from -9.11 on 2024-05-03 Q1, representing a change of 7.04%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 113.53 which is lower than current price 136.47, indicates the company may be overvalued.